TMDX – transmedics group, inc. (US:NASDAQ)

News

TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
TransMedics Group, Inc. (TMDX): A Bull Case Theory [Yahoo! Finance]
TransMedics: Italian NOP Program Reinforces Huge International Opportunity [Seeking Alpha]
TransMedics Group (NASDAQ:TMDX) was downgraded by analysts at Wall Stree
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com